Profitelligence Profitelligence · Filing Ledger Open MDT research →

Form 8-K · Current Report · Filed 2026-09-17

Medtronic Corrects Prospectus for Exchange Offer

On September 17, 2026, Medtronic plc filed an 8-K to correct a typographical error in the prospectus related to the Exchange Offer.

Filer
Medtronic plc MDT · NYSE
Filed
Accession
0001628280-26-062505
CIK
0001613103
Signal
Low impactHealthcare

Details

The error was in the description of guaranteed delivery procedures, which has been revised to clarify the expiration time for a notice of guaranteed delivery. The corrected information is now that the guaranteed delivery period will expire at 5:00 p.m., New York City time, on the second NYSE trading day after the date of execution of such notice of guaranteed delivery.

Items reported

Item events

Reported Item

Pro Forma Financial Information

Market reaction

Close before filing

$92.60

Since filing

+0.0%

Latest close

$92.60

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from MDT reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, MDT insiders reported 29 Form 4 transactions — net selling of $239K.

Full MDT insider history →

About Medtronic plc

Medtronic plc is a global medical technology company that develops, manufactures, and sells device-based therapies and related services for a broad range of chronic and acute health conditions. Headquartered in Dublin, Ireland, and founded in 1949, Medtronic focuses on technologies used by hospitals, clinics, and physicians worldwide. The company operates through four main areas: its Cardiovascular Portfolio, offering products such as heart valves, stents, pacemakers, and defibrillators; its Neuroscience Portfolio, which provides spinal fixation systems, neurostimulation devices, and neurovascular products; its Medical Surgical Portfolio, supplying advanced surgical instruments, energy-based devices, and visualization tools; and its Diabetes Operating Unit, which delivers insulin pumps, continuous glucose monitoring systems, and related consumables. Medtronic plays a significant role in the healthcare sector by providing solutions that support the diagnosis, monitoring, and treatment of complex conditions, serving healthcare providers and patients across the United States, Europe, Japan, and other international markets.

Exchange NYSE Industry Medical Devices Company website ↗

Never miss another MDT filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts